Please login to the form below

Not currently logged in
Email:
Password:

Voltarra names new CEO

Richard Becker has experience at Alcon, Merck, Novartis, OSI, Bayer and BASF

Voltarra Pharmaceuticals has appointed Richard Becker as CEO.

Becker brings more than 20 years' experience to the US biopharma, including senior commercial roles at Alcon, Merck, Novartis, OSI, Bayer and BASF.

In his new role, he leads a company with a pipeline of drugs for rheumatology, central nervous system oncology and immunology.

Voltarra's lead product is VOLT01, which is in late-stage trials for the treatment of osteoarthritis.

Becker said: “The broad portfolio will allow Voltarra Pharmaceuticals to capitalise on development synergies and favourably position the company with external customers. We are extremely excited about the pipeline as well as future plans for a partner in taking VOLT01 to the next stage.”

19th November 2013

From: Sales

Share

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Pegasus

Pegasus inspires healthy decisions through creative, inspirational and integrated communications. Working with ambitious clients, we deliver big ideas and far-reaching...

Latest intelligence

Solaris Health looks at the gene therapy revolution
Gene therapies are bringing new hope for many people with diseases caused by genetic disorders...
PM Society Digital Awards – the power of together
Our chief executive, Emma Statham, writes about the value of awards and the power of together....
Seduction_feature_image_thumb.jpg
Seduce anyone in four simple steps
You know the health of the global economy is dependent on our ability to seduce one another – don’t you? And you know that we need to be able to...

Infographics